BPC 157 Peptide Therapy Advanced Healing & Regeneration BPC 157: Prohibited peptide and unapproved drug in supplements The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 for athletes and injury treatment: Science, safety, and legal concerns FDA to weigh easing limits on unproven peptides